[The treatment of children with difficult to control epilepsy]

R Cuéllar1, M Molinero

  • 1Servicio de Medicina Interna, Hospital Escuela, Tegucigalpa, Honduras. medicos@aph.sdnhon.org.hn

Revista De Neurologia
|October 9, 2003
PubMed

Insights

This survey reviews current pediatric epilepsy management, including surgery, ketogenic diets, and new antiepileptic drugs. It details alternative therapies for difficult-to-control seizures, offering insights into their efficacy and contraindications.

Area of Science:

  • Neurology
  • Pediatrics
  • Epileptology

Context:

  • Pediatric epilepsy management presents unique challenges.
  • Difficult-to-control seizures require diverse therapeutic strategies.
  • Current clinical practices evolve with new treatment options.

Purpose:

  • To survey current management of difficult-to-control epileptic seizures in pediatric practice.
  • To highlight alternative therapies including epilepsy surgery, ketogenic diet, hormone therapy, steroids, gamma globulin, and vagal nerve stimulation.
  • To discuss indications, efficacy, and contraindications of these alternative treatments for various epilepsy types.

Summary:

  • The survey covers established and emerging treatments for pediatric epilepsy.
  • Alternative therapies like epilepsy surgery and ketogenic diets are detailed.
  • New and re-emerging antiepileptic drugs since the 1990s are also discussed.

Impact:

  • Provides a comprehensive overview of pediatric epilepsy treatment options.
  • Informs clinicians on the appropriate use of diverse therapies for refractory epilepsy.
  • Aids in optimizing patient care through evidence-based therapeutic selection.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...